U.S. Markets closed

Innate Pharma S.A. (IPH.PA)

Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
10.52-0.11 (-1.03%)
At close: 5:35PM CEST
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue66,00025,0008,00017,000
Cost of Revenue49,00030,00023,00011,000
Gross Profit17,000-5,000-15,0006,000
Operating Expenses
Research Development----
Selling General and Administrative----
Non Recurring----
Total Operating Expenses58,00036,00028,00019,000
Operating Income or Loss8,000-11,000-20,000-3,000
Income from Continuing Operations
Total Other Income/Expenses Net----
Earnings Before Interest and Taxes8,000-11,000-20,000-3,000
Interest Expense----
Income Before Tax----
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops----
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income13,000-7,000-20,000-3,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares----